Simplex Trading’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,100
Closed -$99K 9762
2025
Q1
$99K Buy
20,100
+19,300
+2,413% +$61.3K ﹤0.01% 5075
2024
Q4
$2K Buy
+800
New +$3.28K ﹤0.01% 8093
2024
Q3
Sell
-1,500
Closed -$5K 9621
2024
Q2
$5K Sell
1,500
-92,400
-98% -$417K ﹤0.01% 7915
2024
Q1
$502K Buy
93,900
+9,400
+11% +$44.2K ﹤0.01% 3862
2023
Q4
$360K Buy
84,500
+84,100
+21,025% +$259K ﹤0.01% 4037
2023
Q3
$1K Sell
400
-1,600
-80% -$10.5K ﹤0.01% 8432
2023
Q2
$20K Buy
2,000
+1,100
+122% +$11.6K ﹤0.01% 6791
2023
Q1
$9K Sell
900
-7,700
-90% -$88K ﹤0.01% 7660
2022
Q4
$80K Buy
8,600
+8,500
+8,500% +$120K ﹤0.01% 5340
2022
Q3
$1K Buy
+100
New +$1.48K ﹤0.01% 9656

Other funds holding TSVT

Simplex Trading's TSVT Position: Q2 2024 in Review

Simplex Trading sold out of 2seventy bio (TSVT) in Q2 2024, closing a stake of 9,491 shares — an estimated $42.8K sold.

Simplex Trading first reported a position in TSVT in Q2 2022 and held it in 7 quarters. The position peaked at $85K in Q3 2022. 115 funds tracked by Wall St. Rank hold TSVT as of Q2 2024.

  • Simplex Trading reported no remaining 2seventy bio position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 9,491 2seventy bio shares in Q2 2024, an estimated $42.8K.
  • Simplex Trading first reported a position in 2seventy bio in Q2 2022 and held it in 7 quarters.
  • Simplex Trading's 2seventy bio position peaked at $85K in Q3 2022.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.